Fair Value Measurement - Estimated Fair Values (Details) - USD ($) $ in Thousands |
Jun. 30, 2025 |
Dec. 31, 2024 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial Assets: | ||||||||||||||
Equity method investments 1 | $ 112,016 | $ 104,640 | ||||||||||||
Equity method investments (Estimated Fair Value) | 112,016 | 104,640 | ||||||||||||
Financial Liabilities: | ||||||||||||||
Term loan Carrying Value | 1,823,832 | 1,825,607 | ||||||||||||
Revolving line of credit | 297,000 | 232,000 | ||||||||||||
Business Combination, Contingent Consideration, Liability | [1] | 5,203 | 5,203 | |||||||||||
U.S. Xpress | Class A | ||||||||||||||
Financial Liabilities: | ||||||||||||||
Business Combination, Contingent Consideration, Liability | [1] | 132,287 | 132,287 | |||||||||||
2021 Term Loan A-2 | ||||||||||||||
Financial Liabilities: | ||||||||||||||
Term loan Carrying Value | [2] | 349,404 | 349,149 | |||||||||||
Term loan, Fair Value | [2] | 350,000 | 350,000 | |||||||||||
2021 Term Loan A-3 | ||||||||||||||
Financial Liabilities: | ||||||||||||||
Term loan Carrying Value | [2] | 759,588 | 779,411 | |||||||||||
Term loan, Fair Value | [2] | 760,000 | 780,000 | |||||||||||
2023 Term Loan | ||||||||||||||
Financial Liabilities: | ||||||||||||||
Term loan Carrying Value | [3] | 249,621 | 249,459 | |||||||||||
Term loan, Fair Value | [3] | 250,000 | 250,000 | |||||||||||
2021 Revolver | ||||||||||||||
Financial Liabilities: | ||||||||||||||
Revolving line of credit | 297,000 | 232,000 | ||||||||||||
U.S. Xpress Revenue Equipment Installment Notes | ||||||||||||||
Financial Liabilities: | ||||||||||||||
Secured Debt | [4] | 153,380 | 192,255 | |||||||||||
Debt Instrument, Fair Value Disclosure | 400 | 600 | ||||||||||||
2021 Prudential Notes | ||||||||||||||
Financial Liabilities: | ||||||||||||||
Term loan Carrying Value | [5] | 8,584 | 16,611 | |||||||||||
Term loan, Fair Value | [5] | 8,584 | 16,621 | |||||||||||
Debt Instrument, Fair Value Disclosure | 400 | 600 | ||||||||||||
Deferred loan costs | 10 | |||||||||||||
2023 RSA | ||||||||||||||
Financial Liabilities: | ||||||||||||||
Accounts receivable securitization | [6] | 439,128 | 458,983 | |||||||||||
Debt Instrument, Fair Value Disclosure | [6] | 439,200 | 459,200 | |||||||||||
Deferred loan costs | $ 100 | $ 200 | ||||||||||||
|
X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Fair value portion of investments accounted under the equity method. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of investment in equity method investee and investment in and advance to affiliate. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Carrying amount of liabilities associated with financial assets accounted for as secured borrowings recognized in the transferor's statement of financial position at the end of each period presented. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|